IMA Lucknow Demands Single Drug Price Policy
The story in brief
The Indian Medical Association (IMA), Lucknow branch, demanded a 'one drug, one price' policy for medicines of comparable quality. The association sought a 30% cap on total trade margins and attributed price differences to market competition, bulk procurement, discounts, batch variations, and shelf life. Dr Shweta Srivastava urged authorities to strengthen quality surveillance through regular sample testing, batch verification, and supply chain monitoring.